

Oramed Pharmaceuticals develops proprietary Protein Oral Delivery technology for the delivery of drugs. Among its major competitors, Oramed Pharmaceuticals is ranked in 5th place for NPS while Novo Nordisk is 1st, and Diasome is 2nd.Their current market cap is $311.62M